Amniotic Products Market Analysis and Forecast to 2032: By Type (Amniotic Membrane, Amniotic Suspensions), Application (Wound Care, Orthopedics, Ophthalmology, Other), End User (Hospitals, Ambulatory Surgical Centers) and Region
Amniotic fluid is the protective liquid enclosed by the amniotic membrane that serves as a cushion for the growing fetus and facilitates the exchange of nutrients, water, and biochemical products between mother and fetus. Amniotic-derived products, comprising amniotic membrane and amniotic fluid products, are one subtype of orthobiologic that is being considered as a potential treatment option through augmentation of joint inflammation and healing. Amniotic membranes (AM) were initially employed for the treatment of skin disorders such as burns, ulcers, and wounds. The presence of a wide range of products of amniotic products used in the treatment of diseases is sustaining the need of healthcare facilities.
Market Drivers
Growing incidence of burn injuries
The high incidence of the burn wound is likely to boost the growth of the market during the forecast period. According to WHO, an estimated 180,000 deaths every year are caused by burns-the high majority occur in low and middle-income economies. In India, over 1,000,000 people are moderately or severely burnt per year. Nearly 173,000 Bangladeshi children are moderately or severely burnt every year. Also, in Bangladesh, Colombia, Egypt, and Pakistan, 17% of children with burns have a temporary disability and 18% have a permanent disability.
Market Opportunity
Implementation of the 21st Century Cures Act (US)
The 21st Century Cures Act was signed into law in the US in December 2016. Among other objectives, this new law has been enacted to advance regenerative medicine research and medical innovation. The Act includes various provisions that may impact the development and approval of several products in the upcoming years. Under this Act, a new “Regenerative Medicine Advanced Therapy” designation has been established, along with a fast-track approval pathway for new regenerative medicine products and therapies. The implementation of this Act can potentially result in the approval of new regenerative medicine products and therapies in the US, as well as stimulate R&D activities in the field of regenerative medicine.
Market Restraints
Complications and limitations associated with the use of amniotic membranes
Amniotic membranes are not to be used comprehensively since there could be an occasional risk of complications. The patient or the recipient of an amniotic membrane could transmit bacterial, viral, or fungal infections if the donors are not adequately screened for communicable diseases. Other risks to the patient/recipient may also occur if the membrane is not processed under sterile conditions, or if the membrane is inappropriately stored. Incidence rates of 1.6% to 8.0% have been reported post amniotic membrane transplantation, with gram-positive isolates being reported most frequently. Moreover, premature degradation of an amniotic membrane and cheese wiring may further lead to frequent and repetitive transplantations, which in itself is a risk.
Impact of COVID-19 on Amniotic Products Market
The COVID-19 outbreak negatively impacted the amniotic product market in 2020 owing to nationwide lockdowns, denied wound care services, and cancelled or postponed elective surgeries. Elective surgeries were being denied (cancelled/postponed) to reserve or redirect the available limited capacities and resources (such as hospital beds and patient care professionals) towards COVID-19 patient care. Adding to that, various countries had imposed lockdowns and curfews to curb the increasing number of COVID-19 cases. Owing to these lockdowns, patients were not able to visit hospitals, OPDs, or clinics. This temporary denial of non-emergent healthcare services is expected to limit the growth of the amniotic product market. However, the demand for amniotic products is expected to rise in the coming years.
Market Segmentation
The market is segmented by type, application, end user and region. By type, the market is divided into amniotic membrane and, amniotic suspensions. By application, the market is bifurcated into wound care , orthopedics, opthalmology and others. By end user, the market is bifurcated into hospitals, and ambulatory surgical centers. By region, the market is classified into North America, Europe, Asia-Pacific, and rest of the world.
Key Players
The global Amniotic Products Market report includes players like MiMedx Group, Inc. (USA), Organogenesis Inc. (USA), Integra LifeSciences (USA), Skye Biologics, Inc. (USA), Stryker Corporation (USA), Amniox Medical (USA), Katena Products, Inc. (USA), Misonix, Inc. (USA), NuCel (USA), and AlloSource (USA)
Amniotic Products Market Report Coverage
- The report offers a comprehensive quantitative as well as qualitative analysis of the current Amniotic Products Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
- The report also covers qualitative as well as quantitative analysis of Amniotic Products Market in terms of revenue ($Million).
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Amniotic Products Market .
- A thorough analysis of market trends and restraints is provided.
- By region as well as country market analysis is also presented in this report.
- Analytical depiction of the Amniotic Products Market along with the current trends and future estimations to depict imminent investment pockets. The overall Amniotic Products Market opportunity is examined by understanding profitable trends to gain a stronger foothold.
- Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Amniotic Products Market are also analyzed.
Table of Contents
Chapter 1. Amniotic Products Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, By Region
3.2. Market Attractiveness Analysis, By Type
3.3. Market Attractiveness Analysis, By End User
3.4. Market Attractiveness Analysis, By Application
Chapter 4. Amniotic Products Market Outlook
4.1. Amniotic Products Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.5.1. Raw Material Suppliers
4.5.2. Manufacturers
4.5.3. Wholesalers and/or Retailers
4.6. Impact of COVID-19 on the Amniotic Products Market
4.7. Impact of the Russia and Ukraine War on the Amniotic Products Market
4.8. Case Study Analysis
4.9. Pricing Analysis
Chapter 5. Amniotic Products Market , By Type
5.1. Market Overview
5.2. Amniotic Membrane
5.2.1. Market Size and Forecast.
5.2.2. Market Size and Forecast, By Region.
5.3. Amniotic Suspensions
5.3.1. Market Size and Forecast.
5.3.2. Market Size and Forecast, By Region.
Chapter 6. Amniotic Products Market , By Application
6.1. Market Overview
6.2. Wound Care
6.2.1. Market Size and Forecast.
6.2.2. Market Size and Forecast, By Region.
6.3. Orthopedics
6.3.1. Market Size and Forecast.
6.3.2. Market Size and Forecast, By Region.
6.4. Ophthalmology
6.4.1. Market Size and Forecast.
6.4.2. Market Size and Forecast, By Region.
6.5. Other
6.5.1. Market Size and Forecast.
6.5.2. Market Size and Forecast, By Region
Chapter 7. Amniotic Products Market , By End User
7.1. Market Overview
7.2. Hospitals
7.2.1. Market Size and Forecast.
7.2.2. Market Size and Forecast, By Region.
7.3. Ambulatory Surgical Centers
7.3.1. Market Size and Forecast.
7.3.2. Market Size and Forecast, By Region.
Chapter 8. Amniotic Products Market , By Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Amniotic Products Market Size and Forecast By Type.
8.2.3. North America Amniotic Products Market Size and Forecast By Application.
8.2.4. North America Amniotic Products Market Size and Forecast By End User.
8.2.5. North America Amniotic Products Market Size and Forecast By Country.
8.2.6. The U.S.
8.2.6.1. The U.S. Amniotic Products Market Size and Forecast By Type.
8.2.6.2. The U.S. Amniotic Products Market Size and Forecast By Application.
8.2.6.3. The U.S. Amniotic Products Market Size and Forecast By End User.
8.2.7. Canada
8.2.7.1. Canada Amniotic Products Market Size and Forecast By Type.
8.2.7.2. Canada Amniotic Products Market Size and Forecast By Application.
8.2.7.3. Canada Amniotic Products Market Size and Forecast By End User.
8.2.8. Mexico
8.2.8.1. Mexico Amniotic Products Market Size and Forecast By Type.
8.2.8.2. Mexico Amniotic Products Market Size and Forecast By Application.
8.2.8.3. Mexico Amniotic Products Market Size and Forecast By End User.
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Amniotic Products Market Size and Forecast By Type.
8.3.3. Europe Amniotic Products Market Size and Forecast By Application.
8.3.4. Europe Amniotic Products Market Size and Forecast By End User.
8.3.5. Europe Amniotic Products Market Size and Forecast By Country.
8.3.6. The U.K.
8.3.6.1. The U.K. Amniotic Products Market Size and Forecast By Type.
8.3.6.2. The U.K. Amniotic Products Market Size and Forecast By Application.
8.3.6.3. The U.K. Amniotic Products Market Size and Forecast By End User.
8.3.7. Germany
8.3.7.1. Germany Amniotic Products Market Size and Forecast By Type.
8.3.7.2. Germany Amniotic Products Market Size and Forecast By Application.
8.3.7.3. Germany Amniotic Products Market Size and Forecast By End User.
8.3.8. France
8.3.8.1. France Amniotic Products Market Size and Forecast By Type.
8.3.8.2. France Amniotic Products Market Size and Forecast By Application.
8.3.8.3. France Amniotic Products Market Size and Forecast By End User.
8.3.9. Spain
8.3.9.1. Spain Amniotic Products Market Size and Forecast By Type.
8.3.9.2. Spain Amniotic Products Market Size and Forecast By Application.
8.3.9.3. Spain Amniotic Products Market Size and Forecast By End User.
8.3.10. Italy
8.3.10.1. Italy Amniotic Products Market Size and Forecast By Type.
8.3.10.2. Italy Amniotic Products Market Size and Forecast By Application.
8.3.10.3. Italy Amniotic Products Market Size and Forecast By End User.
8.3.11. Netherlands
8.3.11.1. Netherlands Amniotic Products Market Size and Forecast By Type.
8.3.11.2. Netherlands Amniotic Products Market Size and Forecast By Application.
8.3.11.3. Netherlands Amniotic Products Market Size and Forecast By End User.
8.3.12. Sweden
8.3.12.1. Sweden Amniotic Products Market Size and Forecast By Type.
8.3.12.2. Sweden Amniotic Products Market Size and Forecast By Application.
8.3.12.3. Sweden Amniotic Products Market Size and Forecast By End User.
8.3.13. Switzerland
8.3.13.1. Switzerland Amniotic Products Market Size and Forecast By Type.
8.3.13.2. Switzerland Amniotic Products Market Size and Forecast By Application.
8.3.13.3. Switzerland Amniotic Products Market Size and Forecast By End User.
8.3.14. Denmark
8.3.14.1. Denmark Amniotic Products Market Size and Forecast By Type.
8.3.14.2. Denmark Amniotic Products Market Size and Forecast By Application.
8.3.14.3. Denmark Amniotic Products Market Size and Forecast By End User.
8.3.15. Finland
8.3.15.1. Finland Amniotic Products Market Size and Forecast By Type.
8.3.15.2. Finland Amniotic Products Market Size and Forecast By Application.
8.3.15.3. Finland Amniotic Products Market Size and Forecast By End User.
8.3.16. Russia
8.3.16.1. Russia Amniotic Products Market Size and Forecast By Type.
8.3.16.2. Russia Amniotic Products Market Size and Forecast By Application.
8.3.16.3. Russia Amniotic Products Market Size and Forecast By End User.
8.3.17. Rest of Europe
8.3.17.1. Rest of Europe Amniotic Products Market Size and Forecast By Type.
8.3.17.2. Rest of Europe Amniotic Products Market Size and Forecast By Application.
8.3.17.3. Rest of Europe Amniotic Products Market Size and Forecast By End User.
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Amniotic Products Market Size and Forecast By Country.
8.4.3. Asia-Pacific Amniotic Products Market Size and Forecast By Type.
8.4.4. Asia-Pacific Amniotic Products Market Size and Forecast By Application.
8.4.5. Asia-Pacific Amniotic Products Market Size and Forecast By End User.
8.4.6. China
8.4.6.1. China Amniotic Products Market Size and Forecast By Type.
8.4.6.2. China Amniotic Products Market Size and Forecast By Application.
8.4.6.3. China Amniotic Products Market Size and Forecast By End User.
8.4.7. India
8.4.7.1. India Amniotic Products Market Size and Forecast By Type.
8.4.7.2. India Amniotic Products Market Size and Forecast By Application.
8.4.7.3. India Amniotic Products Market Size and Forecast By End User.
8.4.8. Japan
8.4.8.1. Japan Amniotic Products Market Size and Forecast By Type.
8.4.8.2. Japan Amniotic Products Market Size and Forecast By Application.
8.4.8.3. Japan Amniotic Products Market Size and Forecast By End User.
8.4.9. South Korea
8.4.9.1. South Korea Amniotic Products Market Size and Forecast By Type.
8.4.9.2. South Korea Amniotic Products Market Size and Forecast By Application.
8.4.9.3. South Korea Amniotic Products Market Size and Forecast By End User.
8.4.10. Australia
8.4.10.1. Australia Amniotic Products Market Size and Forecast By Type.
8.4.10.2. Australia Amniotic Products Market Size and Forecast By Application.
8.4.10.3. Australia Amniotic Products Market Size and Forecast By End User.
8.4.11. Singapore
8.4.11.1. Singapore Amniotic Products Market Size and Forecast By Type.
8.4.11.2. Singapore Amniotic Products Market Size and Forecast By Application.
8.4.11.3. Singapore Amniotic Products Market Size and Forecast By End User.
8.4.12. Indonesia
8.4.12.1. Indonesia Amniotic Products Market Size and Forecast By Type.
8.4.12.2. Indonesia Amniotic Products Market Size and Forecast By Application.
8.4.12.3. Indonesia Amniotic Products Market Size and Forecast By End User.
8.4.13. Taiwan
8.4.13.1. Taiwan Amniotic Products Market Size and Forecast By Type.
8.4.13.2. Taiwan Amniotic Products Market Size and Forecast By Application.
8.4.13.3. Taiwan Amniotic Products Market Size and Forecast By End User.
8.4.14. Malaysia
8.4.14.1. Malaysia Amniotic Products Market Size and Forecast By Type.
8.4.14.2. Malaysia Amniotic Products Market Size and Forecast By Application.
8.4.14.3. Malaysia Amniotic Products Market Size and Forecast By End User.
8.4.15. Rest of APAC
8.4.15.1. Rest of APAC Amniotic Products Market Size and Forecast By Type.
8.4.15.2. Rest of APAC Amniotic Products Market Size and Forecast By Application.
8.4.15.3. Rest of APAC Amniotic Products Market Size and Forecast By End User.
8.5. Rest of The World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of The World Amniotic Products Market Size and Forecast By Type.
8.5.3. Rest of The World Amniotic Products Market Size and Forecast By Application.
8.5.4. Rest of The World Amniotic Products Market Size and Forecast By End User.
8.5.5. Rest of The World Amniotic Products Market Size and Forecast By Country.
8.5.6. Latin America
8.5.6.1. Latin America Amniotic Products Market Size and Forecast By Type.
8.5.6.2. Latin America Amniotic Products Market Size and Forecast By Application.
8.5.6.3. Latin America Amniotic Products Market Size and Forecast By End User.
8.5.7. Middle East
8.5.7.1. Middle East Amniotic Products Market Size and Forecast By Type.
8.5.7.2. Middle East Amniotic Products Market Size and Forecast By Application.
8.5.7.3. Middle East Amniotic Products Market Size and Forecast By End User.
8.5.8. Africa
8.5.8.1. Africa Amniotic Products Market Size and Forecast By Type.
8.5.8.2. Africa Amniotic Products Market Size and Forecast By Application.
8.5.8.3. Africa Amniotic Products Market Size and Forecast By End User.
Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Type Development
9.3.2. Type Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, And Collaborations
9.3.5. Mergers And Acquisitions
Chapter 10. Company Profiles
10.1. MiMedx Group, Inc. (USA)
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Type Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Organogenesis Inc. (USA)
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Type Offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Integra LifeSciences (USA)
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Type Offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Skye Biologics, Inc. (USA)
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Type Offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Stryker Corporation (USA)
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Type Offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Amniox Medical (USA)
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Type Offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Katena Products, Inc. (USA)
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Type Offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Misonix, Inc. (USA)
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Type Offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. NuCel (USA)
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Type Offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. AlloSource (USA)
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Type Offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis
*The List of Company Is Subject To Change During The Final Compilation of The Report
Key Companies
Market Segments
By Type
- Amniotic Membrane
- Amniotic Suspensions
By Application
- Wound Care
- Orthopedics
- Ophthalmology
- Other
By End User
- Hospitals
- Ambulatory Surgical Centers
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- The U.K.
- Germany
- France
- Spain
- Italy
- Netherlands
- Sweden
- Switzerland
- Denmark
- Finland
- Russia
- Rest of Europe
- The Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Singapore
- Indonesia
- Taiwan
- Malaysia
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- The Middle East
- Africa